News
As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...
After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...
The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.
The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Hosted on MSN6d
Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacyWhen asked if the delay resulted from "personnel being shuffled" at the FDA, Kennedy attributed it to the vaccine's ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...
The FDA missed the April 1 regulatory decision target date for Novavax’s Covid-19 vaccine. Politico reported the holdup was due to the intervention of Sara Brenner, the FDA’s principal deputy ...
Directives from President Donald Trump's administration to freeze grant funding from the National Institutes of Health may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results